Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice

키워드

참고문헌 (133)

1. Rahman I, "Regulation of inflammation and redox signaling by dietary polyphenols", Biochem Pharmacol, 72, pp.1439~1452 (2006)
2. Tirkey N, "Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys", BMC Pharmacol, 5, pp.15~ (2005)
3. Gupta SC, "Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals", Cancer Metastasis Rev, 29, pp.405~434 (2010)
4. Sharma S, "Curcumin, the active principle of turmeric(Curcuma longa), ameliorates diabetic nephropathy in rats", Clin Exp Pharmacol Physiol, 33, pp.940~945 (2006)
5. Nishiyama T, "Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice", J Agric Food Chem, 53, pp.959~963 (2005)
6. Sharma OP, "Antioxidant activity of curcumin and related compounds", Biochem Pharmacol, 25, pp.1811~1812 (1976)
7. Sidhu GS, "Enhancement of wound healing by curcumin in animals", Wound Repair Regen, 6, pp.167~177 (1998)
8. Negi PS, "Antibacterial activity of turmeric oil : a byproduct from curcumin manufacture", J Agric Food Chem, 47, pp.4297~4300 (1999)
9. Goel A, "Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs", Nutr Cancer, 62, pp.919~930 (2010)
10. Gupta SC, "Curcumin, a component of turmeric : from farm to pharmacy", Biofactors, 39, pp.2~13 (2013)
11. Reuter S, "Epigenetic changes induced by curcumin and other natural compounds", Genes Nutr, 6, pp.93~108 (2011)
12. Gupta SC, "Therapeutic roles of curcumin : lessons learned from clinical trials", AAPS J, 15, pp.195~218 (2013)
13. Aggarwal BB, "Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals", Annu Rev Nutr, 30, pp.173~199 (2010)
14. Gupta SC, "Multitargeting by curcumin as revealed by molecular interaction studies", Nat Prod Rep, 28, pp.1937~1955 (2011)
15. Anand P, "Bioavailability of curcumin : problems and promises", Mol Pharm, 4, pp.807~818 (2007)
16. Kawanishi N, "Curcumin attenuates oxidative stress following downhill running-induced muscle damage", Biochem Biophys Res Commun, 441, pp.573~578 (2013)
17. Takahashi M, "Effects of curcumin supplementation on exercise-induced oxidative stress in humans", Int J Sports Med (2013)
18. Murakami A, "Curcumin combined with turmerones, essential oil components of turmeric, abolishes inflammation-associated mouse colon carcinogenesis", Biofactors, 39, pp.221~232 (2013)
19. Ryan JL, "Curcumin for radiation dermatitis : a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients", Radiat Res, 180, pp.34~43 (2013)
20. Cheng KW, "Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics", Int J Oncol, 43, pp.895~902 (2013)
21. Phillips J, "Curcumin inhibits UV radiation-induced skin cancer in SKH-1 mice", Otolaryngol Head Neck Surg, 148, pp.797~803 (2013)
22. Clark CA, "Curcumin inhibits carcinogen and nicotine-induced mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma", Cancer Prev Res(Phila), 3, pp.1586~1595 (2010)
23. Lin YC, "Therapeutic efficacy evaluation of curcumin on human oral squamous cell carcinoma xenograft using multimodalities of molecular imaging", Am J Chin Med, 38, pp.343~358 (2010)
24. Yoysungnoen P, "Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice", Clin Hemorheol Microcirc, 34, pp.109~115 (2006)
25. anthracene-induced mammary tumors and lymphomas, "leukemias in Sencar mice", Carcinogenesis, 19, pp.1697~1700 (1998)
26. Perkins S, "Chemopreventive efficacy and pharmacokinetics of curcumin in the min", + mouse, a model of familial adenomatous polyposis, 2002, pp.11, 535~540
27. He HJ, "Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice", World J Diabetes, 3, pp.94~104 (2012)
28. Sidhu GS, "Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice", Wound Repair Regen, 7, pp.362~374 (1999)
29. Patzko A, "Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice", Brain, 135(Pt 12), pp.3551~3566
30. Nemmar A, "Protective effect of curcumin on pulmonary and cardiovascular effects induced by repeated exposure to diesel exhaust particles in mice", PLoS One, 7, pp.e39554~ (2012)
31. Shahani K, "Injectable sustained release microparticles of curcumin: a new concept for cancer chemoprevention", Cancer Res, 70, pp.4443~4452 (2010)
32. Shahani K, "Highly loaded, sustained-release microparticles of curcumin for chemoprevention", J Pharm Sci, 100, pp.2599~2609 (2011)
33. Chowdhury R, "Curcumin attenuation of lipopolysaccharide induced cardiac hypertrophy in rodents", ISRN Inflamm, 2013, pp.539305~ (2013)
34. Du WZ, "Curcumin suppresses malignant glioma cells growth and induces apoptosis by inhibition of SHH", GLI1 signaling pathway in vitro and vivo, 2013, pp.19, 926~936
35. Tu SP, "Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth", Cancer Prev Res(Phila), 5, pp.205~215 (2012)
36. Sun Y, "Neuroprotection and sensorimotor functional improvement by curcumin after intracerebral hemorrhage in mice", J Neurotrauma, 28, pp.2513~2521 (2011)
37. Oh SW, "Curcumin attenuates allergic airway inflammation and hyperresponsiveness in mice through NF-kappaB inhibition", J Ethnopharmacol, 136, pp.414~421 (2011)
38. Smith MR, "Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury", Am J Physiol Lung Cell Mol Physiol, 298, pp.L616~L625 (2010)
39. Kim TH, "Preparation and characterization of water-soluble albuminbound curcumin nanoparticles with improved antitumor activity", Int J Pharm, 403, pp.285~291 (2011)
40. Wang D, "Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKTindependent pathway", Clin Cancer Res, 14, pp.6228~6236 (2008)
41. Shi HS, "A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation", Int J Nanomedicine, 7, pp.2601~2611 (2012)
42. Duarte VM, "Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKbeta protein of the NFkappaB pathway", Mol Cancer Ther, 9, pp.2665~2675 (2010)
43. -luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo, "Int J Cancer", 2011, 1611~1623
44. Gou M, "Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo", Nanoscale, 3, pp.1558~1567 (2011)
45. Sun J, "Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice", PLoS One, 8, pp.e67078~ (2013)
46. Lopez-Jornet P, "Topical curcumin for the healing of carbon dioxide laser skin wounds in mice", Photomed Laser Surg, 29, pp.809~814 (2011)
47. Dovigo LN, "Curcumin-mediated photodynamic inactivation of Candida albicans in a murine model of oral candidiasis", Med Mycol, 51, pp.243~251 (2013)
48. LoTempio MM, "Curcumin suppresses growth of head and neck squamous cell carcinoma", Clin Cancer Res, 11(19 Pt 1), pp.6994~7002 (2005)
49. Wang S, "Formulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcumin", J Drug Target, 20, pp.831~840 (2012)
50. Chen X, "Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel", J Pharm Pharmacol, 65, pp.807~816 (2013)
51. Subhashini, "Intranasal curcumin and its evaluation in murine model of asthma", Int Immunopharmacol, 17, pp.733~743 (2013)
52. Gao Y, "Preparation and characterization of intravenously injectable curcumin nanosuspension", Drug Deliv, 18, pp.131~142 (2011)
53. Gao Y, "Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer", Drug Dev Ind Pharm, 36, pp.1225~1234 (2010)
54. Zhongfa L, "Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice", Cancer Chemother Pharmacol, 69, pp.679~689 (2012)
55. Dandekar P, "Toxicological evaluation of pH-sensitive nanoparticles of curcumin : acute, sub-acute and genotoxicity studies", Food Chem Toxicol, 48, pp.2073~2089 (2010)
56. Peng SF, "Curcumin-loaded nanoparticles enhance apoptotic cell death of U2OS human osteosarcoma cells through the Akt-Bad signaling pathway", Int J Oncol, 44, pp.238~246 (2014)
57. Li H, "Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro", Drug Deliv (2013)[DOI]
58. John MK, "Development and pharmacokinetic evaluation of a curcumin co-solvent formulation", Anticancer Res, 33, pp.4285~4291 (2013)
59. Li C, "Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin", Int J Nanomedicine, 7, pp.5995~6002 (2012)
60. Isacchi B, "Artemisinin and artemisinin plus curcumin liposomal formulations : enhanced antimalarial efficacy against Plasmodium berghei-infected mice", Eur J Pharm Biopharm, 80, pp.528~534 (2012)
61. Agarwal NB, "Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice", Fundam Clin Pharmacol, 27, pp.169~172 (2013)
62. Chen H, "N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin", J Liposome Res, 22, pp.100~109 (2012)
63. Zhang L, "Physical characterization and cellular uptake of propylene glycol liposomes in vitro", Drug Dev Ind Pharm (2012)
64. Dhule SS, "Curcumin-loaded gamma-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma", Nanomedicine, 8, pp.440~451 (2012)
65. Lin YL, "A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells", Nanomedicine, 8, pp.318~327 (2012)
66. Mourtas S, "Curcumin-decorated nanoliposomes with very high affinity for amyloid-beta1-42 peptide", Biomaterials, 32, pp.1635~1645 (2011)
67. Thangapazham RL, "Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells", Int J Oncol, 32, pp.1119~1123 (2008)
68. Pawar YB, "Novel lipid based oral formulation of curcumin : development and optimization by design of experiments approach", Int J Pharm, 436, pp.617~623 (2012)
69. Sun J, "Curcuminloaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability", Colloids Surf B Biointerfaces, 111C, pp.367~375 (2013)
70. Kumar A, "Curcumin loaded nano globules for solubility enhancement : preparation, characterization and ex vivo release study", J Nanosci Nanotechnol, 12, pp.8293~8302 (2012)
71. Saengkrit N, "Influence of curcumin-loaded cationic liposome on anticancer activity for cervical cancer therapy", Colloids Surf B Biointerfaces, 114, pp.349~356 (2014)
72. Ghosh D, "Nanocapsulated curcumin : oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat", Chem Biol Interact, 195, pp.206~214 (2012)
73. Rejinold NS, "Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly(N-isopropylacrylamide)nanocarrier for curcumin drug delivery", Int J Biol Macromol, 49, pp.161~172 (2011)
74. Pandey MK, "Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells", Eur J Pharm Sci, 43, pp.16~24 (2011)
75. Nair KL, "Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier", Int J Pharm, 425, pp.44~52 (2012)
76. Yallapu MM, "Design of curcumin loaded cellulose nanoparticles for prostate cancer", Curr Drug Metab, 13, pp.120~128 (2012)
77. Mukerjee A, "Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy", Anticancer Res, 29, pp.3867~3875 (2009)
78. Gong C, "Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles", Biomaterials, 34, pp.1413~1432 (2013)
79. Marrache S, "Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics", Proc Natl Acad Sci U S A, 109, pp.16288~16293 (2012)
80. Feng R, "Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles", Int J Nanomedicine, 7, pp.4089~4098 (2012)
81. Pandelidou M, "Preparation and characterization of lyophilised egg PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines", J Nanosci Nanotechnol, 11, pp.1259~1266 (2011)
82. Hegge AB, "Formulation and bacterial phototoxicity of curcumin loaded alginate foams for wound treatment applications : studies on curcumin and curcuminoides XLII", J Pharm Sci, 100, pp.174~185 (2011)
83. Liu L, "Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis", Int J Pharm, 443, pp.175~182 (2013)
84. Wang C, "Curcumin inhibits HMGB1 releasing and attenuates concanavalin A-induced hepatitis in mice", Eur J Pharmacol, 697, pp.152~157 (2012)
85. Park JH, "Amphiphilic peptide carrier for the combined delivery of curcumin and plasmid DNA into the lungs", Biomaterials, 33, pp.6542~6550 (2012)
86. Yadav VR, "Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake", Biochem Pharmacol, 80, pp.1021~1032 (2010)
87. Alam S, "Novel dipeptide nanoparticles for effective curcumin delivery", Int J Nanomedicine, 7, pp.4207~4222 (2012)
88. Aditya NP, "Curcuminoids-loaded liposomes in combination with arteether protects against Plasmodium berghei infection in mice", Exp Parasitol, 131, pp.292~299 (2012)
89. Liu CW, "Graphene-based anticancer nanosystem and its biosafety evaluation using a zebrafish model", Biomacromolecules, 14, pp.358~366 (2013)
90. Kumar SS, "Curcumin loaded poly(2-hydroxyethyl methacrylate)nanoparticles from gelled ionic liquid : in vitro cytotoxicity and anti-cancer activity in SKOV-3 cells", Eur J Pharm Sci, 51, pp.34~44 (2014)
91. Gangwar RK, "Curcumin conjugated silica nanoparticles for improving bioavailability and its anticancer applications", J Agric Food Chem, 61, pp.9632~9637 (2013)
92. Singh R, "The influence of Pluronics(R)on dark cytotoxicity, photocytotoxicity, localization and uptake of curcumin in cancer cells : studies of curcumin and curcuminoids XLIX", Photochem Photobiol Sci, 12, pp.559~575 (2013)
93. Suwannateep N, "Comparison of two encapsulated curcumin particular systems contained in different formulations with regard to in vitro skin penetration", Skin Res Technol, 19, pp.1~9 (2013)
94. Wahlstrom B, "A study on the fate of curcumin in the rat", Acta Pharmacol Toxicol(Copenh), 43, pp.86~92 (1978)
95. Shoba G, "Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers", Planta Med, 64, pp.353~356 (1998)
96. Yang KY, "Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS", MS, 2007, pp.853, 183~189
97. Chang MT, "Elevating bioavailability of curcumin via encapsulation with a novel formulation of artificial oil bodies", J Agric Food Chem, 61, pp.9666~9671 (2013)
98. Cheng AL, "Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions", Anticancer Res, 21, pp.2895~2900 (2001)
99. Sharma RA, "Phase I clinical trial of oral curcumin : biomarkers of systemic activity and compliance", Clin Cancer Res, 10, pp.6847~6854 (2004)
100. Guzman-Villanueva D, "Design and in vitro evaluation of a new nanomicroparticulate system for enhanced aqueous-phase solubility of curcumin", Biomed Res Int, 2013, pp.724763~ (2013)
101. Gandapu U, "Curcumin-loaded apotransferrin nanoparticles provide efficient cellular uptake and effectively inhibit HIV-1 replication in vitro", PLoS One, 6, pp.e23388~ (2011)
102. Sasaki H, "Innovative preparation of curcumin for improved oral bioavailability", Biol Pharm Bull, 34, pp.660~665 (2011)
103. Cheng KK, "Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 mice", AAPS J, 15, pp.324~336 (2013)
104. Anand P, "Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo", Biochem Pharmacol, 79, pp.330~338 (2010)
105. Khalil NM, "Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats", Colloids Surf B Biointerfaces, 101, pp.353~360 (2013)
106. Tsai YM, "Effects of polymer molecular weight on relative oral bioavailability of curcumin", Int J Nanomedicine, 7, pp.2957~2966 (2012)
107. Xie X, "PLGA nanoparticles improve the oral bioavailability of curcumin in rats : characterizations and mechanisms", J Agric Food Chem, 59, pp.9280~9289 (2011)
108. Yallapu MM, "Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells", J Colloid Interface Sci, 351, pp.19~29 (2010)
109. Takahashi M, "Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin", J Agric Food Chem, 57, pp.9141~9146 (2009)
110. Rachmawati H, "Molecular inclusion complex of curcumin-beta-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gel", AAPS PharmSciTech, 14, pp.1303~1312 (2013)
111. Sharma V, "Antioxidant potential of curcumin against oxidative insult induced by pentylenetetrazol in epileptic rats", Methods Find Exp Clin Pharmacol, 32, pp.227~232 (2010)
112. Suresh D, "Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats", Indian J Med Res, 131, pp.682~691 (2010)
113. Moorthi C, "Preparation and characterization of curcumin-piperine dual drug loaded nanoparticles", Asian Pac J Trop Biomed, 2, pp.841~848 (2012)
114. Misra R, "Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells", Mol Pharm, 8, pp.852~866 (2011)
115. or CLEFMA in liposomes for treatment of xenograft lung tumor in rats, "Colloids Surf B Biointerfaces", 2011, 329~337
116. Basnet P, "Liposomal delivery system enhances anti-inflammatory properties of curcumin", J Pharm Sci, 101, pp.598~609 (2012)
117. Ryu EK, "Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for β-amyloid plaque imaging", J Med Chem, 49, pp.6111~6119 (2006)
118. Ravindranath V, "Absorption and tissue distribution of curcumin in rats", Toxicology, 16, pp.259~265 (1980)
119. Pan MH, "Biotransformation of curcumin through reduction and glucuronidation in mice", Drug Metab Dispos, 27, pp.486~494 (1999)
120. Sharma RA, "Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer", Clin Cancer Res, 7, pp.1894~1900 (2001)
121. Garcea G, "Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration", Br J Cancer, 90, pp.1011~1015 (2004)
122. Marczylo TH, "Rapid analysis of curcumin and curcumin metabolites in rat biomatrices using a novel ultraperformance liquid chromatography(UPLC) method", J Agric Food Chem, 57, pp.797~803 (2009)
123. curcumin, "Toxicology", 1981, 337~344
124. Ireson C, "Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production", Cancer Res, 61, pp.1058~1064 (2001)
125. Asai A, "Occurrence of orally administered curcuminoid as glucuronide and glucuronide", sulfate conjugates in rat plasma, 2000, pp.67, 2785~2793
126. Holder GM, "The metabolism and excretion of curcumin(1, 7-bis-(4-hydroxy-3-methoxyphenyl)-1, 6-heptadiene-3, 5-dione)in the rat", Xenobiotica, 8, pp.761~768 (1978)
127. Khopde SM, "Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin : possible mechanisms by pulse radiolysis", Biosci Biotechnol Biochem, 64, pp.503~509 (2000)
128. Okada K, "Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice", J Nutr, 131, pp.2090~2095 (2001)
129. Lai CS, "Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis", Mol Nutr Food Res, 55, pp.1819~1828 (2011)
130. Chen CY, "Cytotoxic activity and cell cycle analysis of hexahydrocurcumin on SW 480 human colorectal cancer cells", Nat Prod Commun, 6, pp.1671~1672 (2011)
131. Pan MH, "Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages", Biochem Pharmacol, 60, pp.1665~1676 (2000)
132. Somparn P, "Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives", Biol Pharm Bull, 30, pp.74~78 (2007)
133. Pal A, "Curcumin glucuronides : assessing the proliferative activity against human cell lines", Bioorg Med Chem, 22, pp.435~439 (2014)

관련 논문AI추천